Bupivacaine supraclavicular block — Competitive Intelligence Brief

Bupivacaine supraclavicular block (Bupivacaine supraclavicular block) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic (amide). Area: Anesthesia.

marketed Local anesthetic (amide) Voltage-gated sodium channels Anesthesia Small molecule

Target snapshot

Bupivacaine supraclavicular block (Bupivacaine supraclavicular block) — Jose Soberon, MD. Bupivacaine blocks sodium channels in nerve fibers, preventing the generation and propagation of action potentials to produce local anesthesia.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Bupivacaine supraclavicular block TARGET	Bupivacaine supraclavicular block	Jose Soberon, MD	marketed	Local anesthetic (amide)	Voltage-gated sodium channels
extraarticular injection with ropivacaine	extraarticular injection with ropivacaine	Hvidovre University Hospital	marketed	Local anesthetic	Voltage-gated sodium channels
nortriptyline + topiramate	nortriptyline + topiramate	University of California, Irvine	marketed	Tricyclic antidepressant + anticonvulsant combination	Norepinephrine transporter, serotonin transporter, voltage-gated sodium channels, GABA receptors
Articaine / EPINEPHrine Cartridge	Articaine / EPINEPHrine Cartridge	Universidad de Antioquia	marketed	Local anesthetic with vasopressor	Voltage-gated sodium channels (articaine); alpha-1 and beta-1 adrenergic receptors (epinephrine)
Lidocaine-Prilocaine Cream 2.5-2.5%	Lidocaine-Prilocaine Cream 2.5-2.5%	Centre Hospitalier le Mans	marketed	Local anesthetic	Voltage-gated sodium channels
Lidocaine skin wheal	Lidocaine skin wheal	George Washington University	marketed	Local anesthetic	Voltage-gated sodium channels
Lidoderm 5 % Topical Patch	Lidoderm 5 % Topical Patch	Oregon Health and Science University	marketed	Local anesthetic	Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic (amide) class)

1. Poznan University of Medical Sciences · 4 drugs in this class
2. Nantes University Hospital · 3 drugs in this class
3. Bozyaka Training and Research Hospital · 2 drugs in this class
4. ASST Gaetano Pini-CTO · 2 drugs in this class
5. Centre Hospitalier Universitaire de Nīmes · 1 drug in this class
6. Chiang Mai University · 1 drug in this class
7. Beijing Tiantan Hospital · 1 drug in this class
8. Complejo Hospitalario Universitario de Granada · 1 drug in this class
9. Ciusss de L'Est de l'Île de Montréal · 1 drug in this class
10. China Medical University, China · 1 drug in this class